secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2025-07-18T23:59:59+00:00
Accession:  0001213900-25-065655
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CERO Therapeutics closes additional $397,600 private placement of Series D Preferred Stock
--------------------------------------------------------------------------------

- Issued 497 shares of Series D convertible preferred stock for gross proceeds of approximately $397,600.
- Sale conducted as an Additional Closing under previously announced Securities Purchase Agreement dated April 21, 2025.
- Exempt from registration under Section 4(a)(2) and Rule 506 of the Securities Act.
- Shares are convertible into common stock; terms set forth in Certificate of Designations filed April 22, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025065655/0001213900-25-065655-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025065655/ea0249528-8k_cero.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-065655

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer